Vector-borne diseases (VBDs) represent a significant public health challenge in India, accounting for a considerable proportion of the country's disease burden. This article aims to provide a comprehensive review of the prevalence and management of VBDs in India, targeting healthcare professionals.
India is endemic to numerous VBDs, including malaria, dengue, chikungunya, and Japanese encephalitis. The World Health Organization (WHO) reports that India accounts for 4% of global malaria cases. Furthermore, the country has witnessed an alarming surge in dengue and chikungunya cases over the past decade.
Several factors contribute to the complexity of managing VBDs in India. These include diverse geographical and climatic conditions, high population density, and inadequate public health infrastructure. Additionally, the lack of awareness and delayed diagnosis further exacerbate the situation.
The government of India has initiated several national programs, such as the National Vector Borne Disease Control Programme (NVBDCP), to control and prevent VBDs. These initiatives focus on early diagnosis, prompt treatment, and vector control. Furthermore, community participation and inter-sectoral collaboration are crucial for the success of these programs.
Healthcare professionals play a pivotal role in managing VBDs. Their responsibilities include early detection and treatment, patient education, and participation in community-based preventive measures. They also contribute to surveillance activities, helping identify disease trends and informing public health interventions.
Despite the challenges, significant strides have been made in managing VBDs in India. However, a comprehensive, multi-pronged approach involving healthcare professionals, government bodies, and communities is necessary to further mitigate the burden of these diseases. Continued research and investment in public health infrastructure are also key to achieving this goal.
1.
Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?
2.
Should the UK introduce targeted prostate cancer screening? The case for and against
3.
Real-World EV Plus Pembro Success Seen in Urothelial Cancer
4.
In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.
5.
Investigating the Relationship Between GERD and Anxiety/Depression.
1.
Building Physical Resilience in Chronic Blood Disorders
2.
Can AI Become Our Oncologic Ally? A Look at Artificial Intelligence in Cancer Detection and Control
3.
Artificial Intelligence for Spatial Tumor Evolution Reconstruction
4.
What are Acanthocytes? Understanding the Role of Spiky Red Blood Cells
5.
Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
2.
Understanding Risk Factors Associated With Common Cancers
3.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
4.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
5.
The Role of Hemoglobin in Maintaining Healthy Oxygen Levels
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation